Testosterone Cypionate Injection, USP, CIII, 200 mg/mL, packaged in: a) 10 mL multiple-dose vials (NDC 52536-625-10) and b) 1 mL single dose vials (NDC 52536-625-01), Rx only, Mfd for: Wilshire Pharmaceuticals, Inc., Atlanta, GA 30328.
Published April 12, 2023 · Recall initiated: February 15, 2023
Summary
FDA records drug Class II recall D-0489-2023, published April 12, 2023 and initiated February 15, 2023. Recalling firm: Azurity Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: a) 16,471 vials; b) 43,096 vials; Lot: Lot #23804.034A, 23803.061A, Exp 9/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.
What to do
Voluntary: Firm initiated · Letter
Get an email if TESTOSTERONE CYPIONATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TESTOSTERONE CYPIONATE
- Manufacturer
- Azurity Pharmaceuticals, Inc.
- Distributor
- US Nationwide
- Lot
- Lot #23804.034A, 23803.061A, Exp 9/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATestosterone Cypionate Injection, USP, CIII, 200mg per mL, Rx only, 1mL Single-Dose Vial, Distributed by EugiaApril 23, 2025
- FDAAripiprazole 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDCApril 12, 2023
- FDAAutomated Peritoneal Dialysis System. Used for automatic control of dialysis solution exchanges.April 5, 2023
- FDATestosterone Cypionate Injection, USP, 200mg/mL, CIII, Rx only, 1mL Single-dose vial, Distributed by: SunJuly 20, 2022
- FDATestosterone Cypionate Injection, USP, 200mg/ml, Rx Only, One Single-dose vial, Distributed by: SunJuly 13, 2022
- FDATestosterone Cypionate Injection, USP, 200 mg/mL, 1 mL Single-dose vial per carton, Rx only, Distributed by:June 29, 2022
Questions about this recall
Was Testosterone Cypionate Injection, USP, CIII, 200 mg/mL, packaged in: a) 10 mL multiple-dose vials (NDC 52536-625-10) and b) 1 mL single dose vials (NDC 52536-625-01), Rx only, Mfd for: Wilshire Pharmaceuticals, Inc., Atlanta, GA 30328. recalled?
Yes. FDA published recall D-0489-2023 on April 12, 2023. Reported hazard: cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TESTOSTERONE CYPIONATE.